100.00% -64.97

Alpine Immune Sciences Inc (ALPN)

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Alpine Immune Sciences Inc Stock (ALPN) Company Profile

Alpine Immune Sciences Inc

206-788-4545

201 Elliott Avenue West, Suite 230, Seattle, WA

Prossima data di guadagno

Ultimi documenti SEC

ALPN's Discussions on Twitter

Alpine Immune Sciences Inc Stock (ALPN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-10-18	Iniziato	Berenberg	Buy
2023-10-17	Iniziato	Berenberg	Buy
2023-10-05	Iniziato	RBC Capital Mkts	Outperform
2023-06-26	Ripresa	Oppenheimer	Outperform
2023-01-19	Iniziato	Morgan Stanley	Overweight
2022-11-21	Iniziato	SVB Leerink	Outperform
2020-12-21	Iniziato	H.C. Wainwright	Buy
2020-08-26	Iniziato	Cowen	Outperform

Mostra tutto

Alpine Immune Sciences Inc Borsa (ALPN) Ultime notizie

Alpine Immune Sciences Inc Azioni (ALPN) Dati Finanziari

Alpine Immune Sciences Inc (ALPN)

Alpine Immune Sciences Inc Stock (ALPN) Company Profile

Alpine Immune Sciences Inc Stock (ALPN) Upgrades & Downgrades

Alpine Immune Sciences Inc Borsa (ALPN) Ultime notizie

MyMyasthenia Gravis Clinical Trial Analysis, 2024 Updates | - openPR

Big Drugmakers Are Clinching Smaller Deals - The Wall Street Journal

Big Drugmakers Are Clinching Smaller Deals - Yahoo Finance

Alpine (ALPN) Surges 37% on $4.9B Buyout Offer From Vertex - MSN

Vertex Lifts Revenue Outlook on Growth of Cystic Fibrosis Drugs - Bloomberg

Vertex Pharma raises annual revenue forecast on strong demand for its cystic fibrosis treatments - Yahoo Finance

Vertex Pharmaceuticals Moves Beyond $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney Disease Player Alpine Immune - MSN

Vertex enters into a definitive agreement to acquire Alpine Immune Sciences - World Business Outlook

Even though Alpine Immune Sciences (NASDAQ:ALPN) has lost US$39m market cap in last 7 days, shareholders are still up 200% over 3 years - Yahoo New Zealand News

Fastest Growing Public Companies in Washington State - The Business Journals

Vertex Pharmaceuticals reports $4.4 billion R&D expense post-acquisition - Investing.com

Even though Alpine Immune Sciences (NASDAQ:ALPN) has lost US$39m market cap in last 7 days, shareholders are ... - Yahoo New Zealand News

Has SiBone (SIBN) Outpaced Other Medical Stocks This Year? - Yahoo Lifestyle Singapore

Esperion Therapeutics (ESPR) Moves 6.5% Higher: Will This Strength Last? - Yahoo Lifestyle Singapore

Here's Why You Should Invest in Alpine (ALPN) Stock Now - Yahoo Lifestyle UK

Alpine Immune Sciences (NASDAQ:ALPN) jumps 12% this week, taking three-year gains to 96% - Yahoo Sport Australia

Biopharma index outpaces market benchmarks with an 8% rise - BioWorld Online

Alpine Immune Sciences, Inc. (ALPN) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Sport Australia

Alpine Immune Sciences, Inc. (ALPN) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Movies UK

Alpine Immune Sciences And Abbvie Announce Option And License Agreement For Development And Commercialization Of ALPN-101 - Reuters

Biogen’s HI-Bio Buy Is Latest Biopharma Spending Spree in Projected $257B Immunology Market - BioSpace

Rafferty Asset Management LLC Purchases Shares of 80162 Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - Defense World

Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Given Consensus Rating of “Hold” by Brokerages - Defense World

Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares Bought by Charles Schwab Investment Management Inc. - Defense World

Is a Surprise Coming for Alpine Immune Sciences (ALPN) This Earnings Season? - Yahoo Movies UK

Alpine Immune Sciences, Inc. (ALPN) Moves 9.5% Higher: Will This Strength Last? - Yahoo Singapore News

Swiss National Bank Grows Position in Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - Defense World

Trexquant Investment LP Purchases 25202 Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - Defense World

Alpine Immune (ALPN) Stock Up 19% MTD, Will the Uptick Continue? - Yahoo Movies UK

Franklin Resources Inc. Acquires Shares of 1220333 Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - Defense World

BNP Paribas Financial Markets Has $2.04 Million Stock Position in Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - MarketBeat

BNP Paribas Financial Markets Buys 93423 Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - Defense World

Alpine Immune Sciences, Inc. (ALPN) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Lifestyle Australia

Vertex Pharma's $4.9 billion takeover of Alpine Immune gives it access to a potential billion-dollar franchise, analyst says - MSN

Fenwick Represents Alpine Immune Sciences in its Acquisition by Vertex Pharmaceuticals - Fenwick & West LLP

How To Trade (ALPN) - Stock Traders Daily

Jump Financial LLC Takes Position in Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - MarketBeat

Alpine Immune jumps on report of takeover interest - MSN

Jump Financial LLC Invests $1.06 Million in Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - Defense World

Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares Acquired by New York State Common Retirement Fund - Defense World

Wedbush Reiterates "Neutral" Rating for Alpine Immune Sciences (NASDAQ:ALPN) - MarketBeat

Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

What 11 Analyst Ratings Have To Say About Alpine Immune SciencesAlpine Immune Sciences (NASDAQ:ALPN) - Benzinga

What 11 Analyst Ratings Have To Say About Alpine Immune Sciences - Quantisnow

Alpine Immune Sciences (NASDAQ:ALPN) Reaches New 12-Month High at $64.96 - MarketBeat

Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Sees Significant Drop in Short Interest - MarketBeat

Alpine Immune Sciences, Inc. (ALPN) Earnings Expected to Grow: What to Know Ahead of Q3 Release - Yahoo Movies UK

Alpine Immune Sciences (NASDAQ:ALPN) Sees Strong Trading Volume - Defense World

Strength Seen in Alpine Immune Sciences, Inc. (ALPN): Can Its 7.5% Jump Turn into More Strength? - Yahoo Lifestyle UK

Alpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ... - Yahoo Finance

Alpine Immune stock ticks higher as HSR waiting period for Vertex Pharma deal expires - Seeking Alpha

Alpine Immune Sciences Inc Azioni (ALPN) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a ALPN